Improving delivery of hydrophobic drugs from hydrogels through cyclodextrins
- 27 June 2005
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 74A (3), 454-460
- https://doi.org/10.1002/jbm.a.30374
Abstract
A simple and effective technique of improving delivery of hydrophobic drugs from swellable systems is presented. Conventional methods of drug loading in hydrogel systems are limited by the characteristics of the pharmacological agent. The approach we present uses complexants to modulate drug release. Crosslinked poly(ethylene glycol) (PEG) hydrogels were synthesized, characterized, and used for vascular applications. The release of cyclosporine (CyA) from PEG hydrogels is significantly altered by the sterilization techniques. It was hypothesized that the release of CyA from PEG hydrogels can be modulated by using complexants. A cyclodextrin–CyA complex solution was prepared and used for drug loading. The sterilized PEG hydrogels that were loaded using the cyclodextrin–CyA complex solution had favorable release characteristics compared with the release from PEG hydrogels that were loaded using the conventional technique. Hence, drug release from swellable systems can be tailored by the application of this strategy. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005Keywords
This publication has 41 references indexed in Scilit:
- Release of theophylline and aminophylline from acrylic acid/n-alkyl methacrylate hydrogelsJournal of Polymer Science Part A: Polymer Chemistry, 2004
- Journal of Applied Polymer Science, 2003
- Swelling and protein absorption/desorption of thermo-sensitive lactitol-based polyether polyol hydrogelsPolymer, 2000
- Clinically Significant Drug Interactions with CyclosporinClinical Pharmacokinetics, 1996
- Study on the release of invertase from enzymatically degradable dextran hydrogelsPolymer Gels and Networks, 1995
- Pharmacokinetic Drug Interactions with Cyclosporin (Part I)1Clinical Pharmacokinetics, 1990
- Improvement of proteolytic resistance of immunoadsorbents by chemical modification with polyethylene glycolBiotechnology & Bioengineering, 1989
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986
- CyclosporinNephron, 1980
- Clinical Investigation of Intermediate- and High-Purity Antihaemophilic Factor (Factor VIII) ConcentratesBritish Journal of Haematology, 1971